Press release
Advanced Technology, Application in Various Sectors Driving RNA Therapeutics Market at a CAGR of 28.4% by 2020
RNA Based Therapeutics Market is expected to garner $1.2 billion by 2020, registering a CAGR of 28.4% during the forecast period 2014 - 2020. The Global RNA based therapeutics Market has garnered significant attention in the recent years due to its potential to treat variety of chronic diseases such as cancer, diabetes, AIDS, Tuberculosis and certain cardiovascular conditions.
RNA based therapeutics market is segmented into technology, application, end-users and geography. Technology segment is further categorized as enabling technologies and enabled technologies. The segment of enabling technologies comprises of Microarrays, Labeling, Purification, Linear amplification, qRT-PCR and Inhibition; whereas, enabled technologies includes RNA interference technology (RNAi) and RNA antisense technology. Enabled technologies account for largest market share due to their potential use in therapeutics. The market for RNA based therapeutics is dominated by RNA interference technology as numerous companies have exhibited their interest to develop the RNA drugs using RNAi technology.
Get sample copy of this report at:
www.alliedmarketresearch.com/request-sample/546?utm_source=PC_OPR
RNA based therapeutics have wide applications covering variety of chronic conditions such as Cardiovascular, Kidney Diseases, Oncology, Infectious diseases, Metabolic disorders and Others. The pipeline research is concentrated towards oncology and infectious diseases due to their high prevalence and failure of existing treatment to effectively treat these conditions. The end user market is segmented into research, therapeutics and diagnostics. Currently, research and diagnostics segments are largely exploring the RNA technologies and therapies for the commercialization of RNA drugs.
Geographically, RNA based therapeutics market is segmented into North America, Europe, Asia-Pacific and LAMEA. Potential regions of the respective geographies are strategically analyzed to provide country wise focus on RNA research activities. North America dominates the RNA based therapeutics followed by Europe and Asia-Pacific. The key market players belong to North America and are conducting extensive research to commercialize the therapeutics. Moreover, the growth in North America and Europe is primarily driven by substantial investment on research, advancement in RNA platform technologies, government support and availability of suitable infrastructure to develop the novel RNA based therapies. However, business dynamics in Asia-pacific is anticipated to offer tremendous opportunities to major players of this market as cost of clinical research is less in this region as compared to North America and Europe.
Key players in the market:
• Quark Pharmaceuticals Inc. (USA)
• Alnylam Pharmaceuticals Inc. (USA)
• Dicerna Pharmaceuticals Inc. (USA)
• Tekmira Pharmaceuticals Corp. (Canada)
• Benitec Biopharma Limited (Australia)
• Genzyme Corporation (USA)
• ISIS pharmaceuticals Inc (USA)
• Silence Therapeutics PLC (UK)
• Cenix BioScience GmbH (Germany)
Send Enquiry on this report @
www.alliedmarketresearch.com/purchase-enquiry/546?utm_source=PC_OPR
About Us:
Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of "Market Research Reports" and "Business Intelligence Solutions." AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.
We are in professional corporate relations with various companies and this helps us in digging out market data that helps us generate accurate research data tables and confirms utmost accuracy in our market forecasting. Each and every data presented in the reports published by us is extracted through primary interviews with top officials from leading companies of domain concerned. Our secondary data procurement methodology includes deep online and offline research and discussion with knowledgeable professionals and analysts in the industry.
Contact:
Sona Padman
5933 NE Win Sivers Drive
#205, Portland, OR 97220
United States
Toll Free: +1-800-792-5285
UK: +44-845-528-1300
Hong Kong: +852-301-84916
India (Pune): +91-20-66346060
Fax: +1?855?550-5975
help@alliedmarketresearch.com
Web: www.alliedmarketresearch.com
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Advanced Technology, Application in Various Sectors Driving RNA Therapeutics Market at a CAGR of 28.4% by 2020 here
News-ID: 1592823 • Views: …
More Releases from Allied Market Research
3D Printing Filament Market Comprehensive Growth Outlook and Trend Analysis, 202 …
According to the report, the global 3D printing filament market was valued at $0.9 billion in 2023 and is projected to reach $2.3 billion by 2031, registering a CAGR of 12.8% from 2024 to 2031.
Download Sample Pages of Research Overview: https://www.alliedmarketresearch.com/3d-printing-filament-market-A11572
Key Growth Drivers:
The growth of the 3D printing filament market is fueled by continuous advancements in filament materials-such as carbon fiber-reinforced composites, metal-infused filaments, and high-performance engineering plastics. These innovations…
Wet Chemicals Market Detailed Analysis, Growth Trends, and Future Outlook 2025-2 …
According to a recent report by Allied Market Research (AMR), the global wet chemicals market is poised for substantial growth, projected to reach a value of $5.9 billion by 2031, up from $3.2 billion in 2021. This comprehensive analysis explores market dynamics, growth drivers, and strategic initiatives while highlighting key opportunities across regions and industry segments.
Download Sample Pages of Research Overview: https://www.alliedmarketresearch.com/request-sample/A17425
The study delves into development trends, investment frameworks, and…
Nonwoven Fabrics Market Outlook to 2033 Projected High CAGR and Growth Opportuni …
A new report titled "Nonwoven Fabrics Market by Polymer Type (Polypropylene (PP), Polyethylene (PE), Polyethylene Terephthalate (PET), Wood Pulp, Rayon, and Others), Function (Disposables and Durables), Technology (Spunbond, Dry Laid, Air Laid, Wet Laid, Meltblown, and Others), and Application (Hygiene, Wipes, Medical, Filtration, Automotive, Building & Construction, and Others): Global Opportunity Analysis and Industry Forecast, 2024-2033" has been released by Allied Market Research.
Key Highlights:
- Market Size (2023): $58.4 Billion
- Projected…
Utilities Asset Management Market Poised for 11.3% CAGR Growth, Key Players, Mar …
According to the report published by Allied Market Research, the global utilities asset management market generated $4.3 billion in 2021, and is projected to reach $12.4 billion by 2031, growing at a CAGR of 11.3% from 2022 to 2031.
The report offers a detailed analysis of the top winning strategies, evolving market trends, market size and estimations, value chain, key investment pockets, drivers & opportunities, competitive landscape and regional landscape.…
More Releases for RNA
CD Formulation Launches Custom Circular RNA Synthesis Service to Accelerate RNA …
CD Formulation introduces a customizable circRNA synthesis service, delivering high-quality, stable circRNAs for therapeutics, vaccines, and gene research, supported by advanced design and QC processes.
CD Formulation, a leading provider of advanced small nucleic acid synthesis [https://www.formulationbio.com/nucleic-acid/custom-small-nucleic-acid-synthesis.html] solutions, is proud to announce the launch of its fully customizable circular RNA (circRNA) synthesis service. This new service addresses the growing need for stable, non-immunogenic RNA molecules for therapeutic development, vaccine research, and…
Self-Amplifying RNA Synthesis Market Gains Traction as Biotech Firms Embrace Sca …
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the " Self-Amplifying RNA Synthesis Market- (By Product & Service (Products (Enzymes & Reagents, Premade saRNA, Others), Custom Synthesis Services), By Application (Therapeutics Development (Oncology, Infectious Diseases, Others), Biomedical Research), By End-User (Pharmaceutical & Biotechnology Companies, Academic & Research Institutes, Others)), Trends, Industry Competition Analysis, Revenue and Forecast To 2034."
According to the latest research by InsightAce Analytic,…
RNA Extraction and RNA Purification Market: Growth, Trends & Competitive Landsca …
The global RNA Extraction and RNA Purification Market is expected to grow at 6.3% CAGR from 2025 to 2032.
This Market Report is the result of extensive research and analysis conducted by our team of experienced market researchers through -
• 70% efforts of Primary Research
• 15% efforts of Secondary Research
• 15% efforts from the subscription to Paid database providing industry overview, macro and micro economics factors, and financials of private limited…
RNA Targeting Small Molecules Therapeutics Market: Exponential Growth with Risin …
Estimations Predict a CAGR of 29.8% by 2029 in Global RNA Targeting Small Molecules Therapeutics Market Boosted by Precision Medicine, RNA Biomarker Identification and RNA Genetic Manipulation
What Is The Projected Market Size of The Global RNA Targeting Small Molecules Therapeutics Market And Its Growth Rate?
• The market will grow from $6.1 billion in 2024 to $7.87 billion in 2025 at a compound annual growth rate (CAGR) of 28.9%.
• Expected exponential…
Global DNARNA Extraction Kit Market by Type (Cell-free DNA (cfDNA), Sequence-spe …
"DNARNA Extraction Kit Market" is segmented by Company, Region (country), By Type, Application, stakeholders and other participants. This report provides an analysis of revenue and forecast across Type and Application segments for 2023-2032.
The market for DNARNA Extraction Kits has been thoroughly researched via primary and secondary sources to produce this research study. Along with a competitive analysis of the market, segmented by application, type, and geographical trends, it offers a…
Cancer RNA Expression Market to Reap Excessive Revenues by 2028(By sequencing te …
Worldwide cancer is one of the leading cause of death and effective way of treating it still looks unaccomplished in most parts of the world. The factors which influence the successful treatment of cancer are different depending on the stage of diagnosis, treatment availability and availability of trained healthcare professionals coupled with high economic burden of the disease. The gene expression of cancerous cells varies by cancer type and may…
